Murine CD4 T Cells Produce a New Form of TGF-β as Measured by a Newly Developed TGF-β Bioassay by Oida, Takatoku & Weiner, Howard L.
Murine CD4 T Cells Produce a New Form of TGF-b as
Measured by a Newly Developed TGF-b Bioassay
Takatoku Oida
¤, Howard L. Weiner*
Center for Neurologic Diseases, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America
Abstract
Background: It is generally assumed that T cells do not produce active TGF-b since active TGF-b as measured in
supernatants by ELISA without acidification is usually not detectable. However, it is possible that active TGF-b from T cells
may take a special form which is not detectable by ELISA.
Methodology/Principal Findings: We constructed a TGF-b bioassay which can detect both soluble and membrane-bound
forms of TGF-b from T cells. For this bioassay, 293T cells were transduced with (caga)12 Smad binding element-luciferase
along with CD32 (Fc receptor) and CD86. The resulting cells act as artificial antigen presenting cells in the presence of anti-
CD3 and produce luciferase in response to biologically active TGF-b. We co-cultured pre-activated murine CD4
+CD25
2 T
cells or CD4
+CD25
+ T cells with the 293T-caga-Luc-CD32-CD86 reporter cells in the presence of anti-CD3 and IL-2.
CD4
+CD25
2 T cells induced higher luciferase in the reporter cells than CD4
+CD25
+ T cells. This T cell-produced TGF-b is in a
soluble form since T cell culture supernatants contained the TGF-b activity. The TGF-b activity was neutralized with an anti-
mouse LAP mAb or an anti-latent TGF-b/pro-TGF-b mAb, but not with anti-active TGF-b Abs. An anti-mouse LAP mAb
removed virtually all acid activatable latent TGF-b from the T cell culture supernatant, but not the ability to induce TGF-b
signaling in the reporter cells. The induction of TGF-b signaling by T cell culture supernatants was cell type-specific.
Conclusions/Significance: A newly developed 293T-caga-Luc-CD32-CD86 reporter cell bioassay demonstrated that murine
CD4 T cells produce an unconventional form of TGF-b which can induce TGF-b signaling. This new form of TGF-b contains
LAP as a component. Our finding of a new form of T cell-produced TGF-b and the newly developed TGF-b bioassay system
will provide a new avenue to investigate T cell function of the immune system.
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Introduction
TGF-b is an immunoregulatory cytokine that controls immune
responses by multiple mechanisms [1]. TGF-b-deficient mice
manifest an autoimmune syndrome and do not survive longer than
3–4 wks after birth [2], [3]. Moreover, it has been shown that
TGF-b initiates Th17 differentiation in combination with IL-6 or
IL-21 [4], [5], [6], [7], [8]. Although IL-17 is a dominant factor in
the induction of autoimmune diseases such as experimental
autoimmune encephalomyelitis [9] and collagen-induced arthritis
[10], IL-17 production is not seen in TGF-b1
2/2 mice [5].
Although many cell types produce TGF-b, T cell-produced TGF-
b is plays an important role in the control of autoimmune
responses and Th17 differentiation. Thus, T cell-specific TGF-b
conditional knockout mice develop fatal autoimmune disease even
though they survive longer than TGF-b
2/2 mice [11], and Th17
differentiation is hampered in these mice [11], indicating that
TGF-b produced by T cells themselves is required for Th17
differentiation.
TGF-b is produced as a pro-form (pro-TGF-b), and is
intracellularly processed by furin proprotein convertase into latent
TGF-b. Latent TGF-b is a non-covalently associated complex
consisting of latency-associated peptide (LAP) which is the N-
terminal portion of pro-TGF-b, and mature TGF-b which is made
of the C-terminal of pro-TGF-b. Latent TGF-b cannot bind TGF-
b receptors and thus further activation processes are required for
biological activity [12]. It is unknown how T cell-produced TGF-b
is activated.
Murine T cell culture supernatants usually do not contain active
TGF-b when measured by ELISA without acidification. Thus, it is
generally believed that T cells do not produce active TGF-b.
Nakamura et al. [13] first reported that murine CD4
+CD25
+
regulatory T cells (Tregs) expressed surface LAP and/or TGF-b
(LAP/TGF-b), and they proposed that the membrane-bound TGF-b
mediated suppressive activity of Tregs. We also confirmed that
Foxp3
+ Tregs express surface LAP/TGF-b by using our newly
developed anti-mouse LAP/TGF-b mAbs [14]. Human FOXP3
+
Tregs have also been shown to express surface LAP [15], [16], [17]. It
is possible that surface LAP/TGF-b on T cells can trigger TGF-b
s i g n a l i n gi nt a r g e tc e l l sb yac e l l - c e l lc o n t a c tm a n n e r ,g i v et h a ta c t i v e
TGF-b is usually not detectable from T cell culture supernatants by
ELISA. Alternatively, active TGF-b may be a rapidly-consumed,
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experimental evidence thus far, it is also possible that T cells produce
biologically active TGF-b in a form that is not detectable by ELISA.
Given these possibilities, we developed a bioassay system which
detects TGF-b activity, rather than the specific molecular form
(the 25 kDa free TGF-b dimer) that an ELISA detects. This new
bioassay consists of reporter cells that have direct contact with T
cells and which can sense both short-lived and membrane-bound
forms of TGF-b. 293T cells were transduced with a TGF-b
reporter vector which has repeated the CAGA Smad binding
elements in the promoter followed by luciferase, and with CD32
(Fc receptor) and CD86.
By using the newly developed 293T-caga-Luc-CD32-CD86
reporter cells, we found that pre-activated murine CD4 T cells
induced high luciferase signals in the reporter cells. Although
Foxp3
+ T cells expressed surface LAP/TGF-b [14], pre-activated
CD4
+CD25
2 T cells induced much higher TGF-b signal than
pre-activated CD4
+CD25
+ T cells. The T cell-produced TGF-b
was a soluble form since T cell culture supernatants contained
TGF-b activity. The T cell-produced TGF-b is not the canonical
25 kDa mature TGF-b since a TGF-b ELISA did not detect the
25 kDa mature TGF-b form in the same T cell culture
supernatants. Surprisingly, the TGF-b activity in T cell culture
supernatants was neutralized with an anti-LAP mAb and with an
anti-pro-TGF-b/latent TGF-b mAb, but not with anti-mature
TGF-b Abs. TGF-b activity remained in culture supernatants even
after the culture supernatant was treated with immobilized anti-
LAP mAb by which latent TGF-b detected by TGF-b ELISA after
acidification was virtually all depleted. Thus, T cell-produced
TGF-b takes a unique molecular form which contains LAP as a
component, and from which 25 kDa mature TGF-b is not
released even after acidification. T cell-produced TGF-b initiated
TGF-b signaling not in all cell types, suggesting that cell type-
specific factors are required to sense the T cell-produced TGF-b.
Results
Generation of a TGF-b reporter cell line
It has been reported that CAGA is a Smad binding element and
a promoter assay vector containing tandem repeats of CAGA in
the minimum promoter region ((caga)12-MLP-Luc) is a sensitive
and specific TGF-b reporter vector [18], [19]. We inserted the
(caga)12-MLP-Luc segment into a promoterless lentiviral vector
(pSMPUW) to construct a lentivirus based universal TGF-b
reporter vector (pSMPUW-(caga)12-MLP-Luc-UbC-EGFP.puro-
RRE) (Figure 1A).
Human embryonic kidney 293T cells were then transduced
with the TGF-b reporter vector (293T-caga-Luc cells). The
response curve of 293T-caga-Luc cells to recombinant TGF-b
was able to detect as little as 2 pg/ml recombinant human TGF-b
Figure 1. Generation of a TGF-b reporter cell line. (A) Schematic diagram of pSMPUW-(caga)12-Luc lentivirus based TGF-b reporter vector. (B)
Representative luciferase response of 293T-caga cells to recombinant TGF-b. 293T cells were transduced with the pSMPUW-(caga)12-Luc vector, and
cultured in the presence of recombinant human TGF-b for 16 hrs. Luciferase activity was measured from the cell lysates. Mean 6 S.D. from duplicates
are shown. (C) Schematic diagram of generation of 293T-caga-Luc-CD32-CD86 cells and how the cells function as artificial antigen presenting cells.
doi:10.1371/journal.pone.0018365.g001
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antigen presenting cells, the 293T-caga-Luc cells were transduced
with mouse CD32 (Fc receptor) and mouse CD86 retroviral
vectors (Figure 1C). Serpinb9 (granzyme B inhibitor) and Serpinb9b
(granzyme M inhibitor) were also retrovirally expressed. These
granzyme inhibitor genes suppressed CD4 T cell-mediated killing
of CD32- and CD86-transduced mink lung epithelial cells (MLEC)
(data not shown), and it is expected that the granzyme inhibitor
genes protect 293T cells from CD4 T cell-mediated killing, too,
although 293T cells are relatively resistant to CD4 cell-mediated
killing without these gene transductions. The transduced 293T
cells were cloned at each step and high responding or high
expressing clones were selected. The resulting TGF-b reporter cell
line is termed as 293T-caga-Luc-CD32-CD86.
Detection of TGF-b activity from CD4 T cells in coculture
We tested whether murine CD4 T cells have TGF-b activity by
using the 293T-caga-Luc-CD32-CD86 TGF-b reporter cells. For
these experiments we co-cultured T cells with 293T-caga-Luc-
CD32-CD86 TGF-b reporter cells in presence of anti-CD3
antibody. In preliminary experiments, we found that freshly
prepared CD4 T cells barely induced luciferase during 24 hr co-
culture. Then, we tested pre-activated CD4 T cells. Thus, mouse
CD4 T cells were stimulated with plate-bound anti-CD3/CD28 for
two days, rested for one day and then co-cultured with 293T-cgga-
Luc-CD32-CD86 TGF-b reporter cells with anti-CD3 for 16 hrs
(Figure 2A). As shown Figure 2B, CD4 T cells induced high
luciferase activity in a cell number dependent manner. Interestingly,
although the response to recombinant TGF-b became saturated
above 200 pg/ml, CD4 T cells often induced higher luciferase
activity than the saturation point. It should be noted that the re-
stimulation at this time point minimally induced activation-induced
cell death, while re-stimulation at later time points induced notable
cell death under microscopic observation. Higher luciferase signal
was observed at later time points when anti-FasL mAb was added to
block the activation-induced cell death (Figure S1). Thus, it is not
likely that the TGF-b activity is generated from dying T cells.
TGF-b activity from Tregs
We previously reported that activated Fox3
+ CD4 T cells
express surface LAP/TGF-b using our newly developed anti-
mouse LAP/TGF-b mAbs [14]. We tested whether these surface
LAP/TGF-b-expressing Foxp3
+ CD4 T cells were CD4 T cells
with TGF-b activity. CD4
+CD25
+ (.90% Foxp3
+) cells and
CD4
+CD25
2 (.98% Foxp3
2) cells were isolated and stimulated
with plate-bound anti-CD3/CD28 in the presence of IL-2 for two
days and rested for one day in presence of IL-2. They were then
co-cultured with 293T-caga-Luc-CD32-CD86 TGF-b reporter
cells in presence of anti-CD3 and IL-2 for 16 hrs. The T cells have
tight cell to cell contact with the reporter cells both by the CD32-
anchored anti-CD3 Ab and by CD86; thus the reporter cells
should be able to sense membrane-bound TGF-b activity if
Figure 2. TGF-b bioassay in co-culture. Mouse CD4 T cells were stimulated with plate-bound anti-CD3/CD28 for 2 days, and rested for 1 day. The
pre-activated CD4 T cells were recovered, and the indicated numbers of T cells were added to 293T-caga-Luc-CD32-CD86 cells with 0.5 mg/ml anti-
CD3 antibody. Recombinant human TGF-b was also added as a standard. After 16 hr of culture, the reporter cells were lysed and the luciferase activity
was measured. Error bars represent mean 6 S.D. of duplicates.
doi:10.1371/journal.pone.0018365.g002
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+CD25
+ T cells had less TGF-
b activity in the co-culture bioassay than CD4
+CD25
2 T cells.
These results demonstrate that non-Tregs are the main CD4 T
cells with TGF-b activity by the reporter assay.
No requirement for direct contact with T cells for
induction of TGF-b signaling
Although we initially anticipated that membrane-bound TGF-b
on Foxp3
+ CD4 T cells would trigger TGF-b signaling in the
reporter cells, as described above, this was not the case. To further
investigate the role of membrane-bound TGF-b, we asked whether
direct contact between T cells and the reporter cells was required
to initiate TGF-b signaling. In order to address this question,
293T-caga-Luc cells that did not have surface CD32 or CD86
were mixed with CD32- and CD86-trandsduced 293T cells that
did not have the (caga)12-Luc reporter (Figure 4B). If T-reporter
contact was required to present T cell-produced TGF-b to TGF-b
receptors on the reporter cells, there would be diminished
induction of luciferase in this condition. We found, however, that
pre-activated CD4 T cells stimulated with 293T-CD32-CD86 cells
in presence of anti-CD3 induced TGF-b signaling in 293T-caga-
Luc cells as well as or better than the condition in which 293T-
caga-Luc-CD32-CD86 cells were used as reporter cells (Figure 4A).
This result indicates that the T cell-produced TGF-b that results in
TGF-b activity as measured in our reported system is soluble and
can diffuse to adjacent cells.
TGF-b activity in T cell culture supernatants
After demonstrating that T cell-produced TGF-b is in a soluble
form, we next asked whether this form accumulates in culture
supernatants. To address this, pre-activated CD4
+CD25
2 T cells
(anti-CD3/28 for 3 days) were re-stimulated with the reporter cells
plus anti-CD3 for 16 hrs as the co-culture assay (Figure 5A), and
the culture supernatants were also taken at the end of the assay.
The culture supernatants were added to fresh 293T-caga-Luc-
CD32-CD86 TGF-b reporter cells (without live T cells), and the
reporter cells were cultured for 9 hrs (Figure 5B). We found that
the T cell culture supernatant from the 1610
5 cells/well induced
luciferase activity equivalent to approximately 200 pg/ml of
recombinant human TGF-b. Thus, TGF-b activity accumulates
in T cell culture supernatants. We also measured the same culture
supernatant by TGF-b ELISA without acidification which detects
the 25 kDa free TGF-b dimer and found that the amount of active
TGF-b as measured by the TGF-b ELISA was 10 pg/ml. ‘‘Total’’
TGF-b as measured by ELISA after acidification was found to be
486 pg/ml (Table 1). These results indicate that the T cell-
produced TGF-b activity takes an unconventional form which is
different from the 25 kDa free TGF-b dimer and is not detectable
by ELISA.
T cell-produced TGF-b activity induces Smad2
phosphorylation in 293T-caga-Luc-CD32-CD86 cells
To confirm that the luciferase activity was a consequence of
TGF-b signaling, we determined Smad2 phosphorylation in
293T-caga-Luc-CD32-CD86 cells after exposure to T cell
culture supernatants. T cell culture supernatants from anti-
CD3/CD28-stimulated cultures of pre-activated CD4
+CD25
2
T cells contained higher TGF-b activity (2–3 ng/ml recombi-
nant TGF-b equivalent) than cultures re-stimulated with 293T-
caga-Luc-CD32-CD86 reporter cells/anti-CD3 (data not
shown). Thus, we used culture supernatants from plate-bound
anti-CD3/CD28 re-stimulated CD4
+CD25
2 T cells for further
studies. 1 ng/ml recombinant human TGF-b o rad i l u t e dTc e l l
culture supernatant adjusted to the equivalent TGF-b activity
determined by the 293T-caga-Luc-CD32-CD86 TGF-b bioas-
say was added to 293T-caga-Luc-CD32-CD86 cells for the
indicated time, and the cell lysates were run on SDS-PAGE and
blotted with anti-phospho-Smad2 antibody. Although the T cell
culture supernatant was diluted to normalize the TGF-b
activity, the T cell culture supernatant induced stronger Smad2
phosphorylation than recombinant TGF-b at all the time points
(Figure 6). This result suggests that T cell-produced TGF-b
activity is qualitatively different from the 25 kDa free TGF-b
dimer.
Figure 3. TGF-b bioassay of CD4
+CD25
+ Tregs. Mouse CD4
+CD25
+ T cells and CD4
+CD25
2 T cells were stimulated with plate-bound anti-CD3/
CD28 for 2 days, and rested for 1 day in presence of 100 U/ml IL-2. These pre-activated CD4 T cells were recovered, and the indicated numbers of T
cells were added to 293T-caga-Luc-CD32-CD86 cells with 0.5 mg/ml anti-CD3 antibody and 100 U/ml IL-2 for 16 hrs after which luciferase activity was
measured. Error bars represent mean 6 S.D. of duplicates.
doi:10.1371/journal.pone.0018365.g003
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detectable ‘‘total’’ TGF-b fraction
TGF-b measured by ELISA after acidification is termed ‘‘total’’
TGF-b. This is based on the assumption that following acidification,
the 25 kDa free TGF-b dimer is released from any form of TGF-b,
such as the small latent TGF-b complex and the large latent TGF-b
complexes. We thus asked whether T-cell produced TGF-b activity
resides in the ‘‘total’’ TGF-b fraction. Since FBS-derived latent
TGF-b affects TGF-b ELISA after acidification, we used TGF-b-
depleted FBS for the culture medium [20]. The background bovine
TGF-b remaining in the 10% TGF-b-depleted FBS-supplemented
medium was 148 pg/ml. We treated a T cell culture supernatant
with anti-LAPmAb TW7-16B4-coupled magneticbeads(oranIgG1
isotype control mAb MOPC21) to deplete latent TGF-b in the
supernatant. The amount of ‘‘total’’ TGF-b detected by ELISA after
acidification in control MOPC21-treated T cell culture supernatant
was 1,318 pg/ml, whereas the anti-LAP TW7-16B4-treated T cell
culture supernatant contained 126 pg/ml ‘‘total’’ TGF-b
(Figure 7A). Since anti-murine LAP TW7-16B4 mAb does not
cross-react with bovine LAP (data notshown),weconclude thatall T
cell-derived ‘‘total’’ TGF-b was removed by the TW7-16B4-coupled
magnetic bead treatment. However, TGF-b activity in the TW7-
16B4-treated T cell culture supernatant was intact since the anti-
LAP TW7-16B4-treated T cell culture supernatant induced an
identical TGF-b response in 293T-caga-Luc-CD32-CD86 reporter
cells as the control MOPC21-treated T cell culture supernatant
Figure 4. Investigation of requirement for direct contact between T cells and TGF-b reporter cells. (A) 293T-caga-Luc-CD32-CD86 cells
were mixed with an equal number of un-manipulated 293T cells. Under this condition, a single 293T-caga-Luc-CD32-CD86 cell stimulates CD4 T cells
and responds to TGF-b activity produced by the same T cells. (B) 293T-caga cells that did not have CD32 or CD86 were mixed with 293T-CD32-CD86
cells lacking the (caga)12-Luc reporter. Under this condition the 293T-caga reporter cells have minimal contact with CD4 T cells.
doi:10.1371/journal.pone.0018365.g004
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is not contained in the ELISA detectable ‘‘total’’ TGF-b fraction.
Neutralization of T cell-produced TGF-b activity with
anti-LAP/latent TGF-b mAbs
Since our results above indicate that T cell-produced TGF-b
activity takes a form that is different from the 25 kDa free TGF-b
dimer, we tested anti-active TGF-b Abs and anti-mouse LAP/
latent TGF-b mAbs to better understand the structure of T cell-
produced TGF-b. Recombinant TGF-b (100 pg/ml) and a T cell
culture supernatant diluted to the equivalent activity were treated
with 50 mg/ml of anti-TGF-b Abs (1D11 or chicken polyclonal
anti-TGF-b), anti-mouse LAP mAb (TW7-20B9), or anti-latent
TGF-b/pro-TGF-b mAb (TW7-28G11), and then tested for
TGF-b activity by the 293T-caga-Luc-CD32-CD86 bioassay. As
expected anti-TGF-b Abs neutralized recombinant TGF-b
activity, whereas anti-LAP/anti-latent TGF-b/pro-TGF-b mAbs
did not (Figure 8A). Surprisingly, anti-TGF-b Abs did not
neutralize TGF-b activity in the T cell culture supernatant
(Figure 8B). The ALK5 inhibitor II [14] completely blocked
luciferase induction by the T cell culture supernatant (Figure 8B),
confirming that the luciferase production was downstream of the
TGF-b signaling. On the other hand, anti-LAP mAb TW7-20B9
and anti-latent TGF-b/pro-TGF-b TW7-28G11 inhibited TGF-b
activity in the culture supernatant (Figure 8B). Thus, T-cell
Figure 5. TGF-b bioassay from T cell culture supernatants. (A) Pre-activated CD4
+CD25
2 T cells were re-stimulated with 293T-caga-Luc-CD32-
CD86 cells in the presence of anti-CD3 as a co-culture assay. (B) Supernatants were taken from the co-culture assay, added to new wells of 293T-caga-
Luc-CD32-CD86 reporter cells and luciferase activity was measured. Error bars represent mean 6 S.D. of duplicates.
doi:10.1371/journal.pone.0018365.g005
Table 1. TGF-b in a T cell culture supernatant was measured
by the 293T-caga-CD32-CD86-caga bioassay (TGF-b activity),
by ELISA without acidification (the 25 kDa free TGF-b dimer),
and by ELISA after acidification ( ‘‘total TGF-b’’).
TGF-b in culture supernatant
293T-(caga)12-Luc ELISA ELISA
bioassay without acidification after acidification
(activity) (25 kDa free dimer) (‘‘total’’)
,200 pg/ml 10 pg/ml 486 pg/ml
doi:10.1371/journal.pone.0018365.t001
Figure 6. Smad2 phosphorylation by T cell culture superna-
tants. Recombinant TGF-b (1 ng/ml) or a T cell culture supernatant
containing equivalent amount of TGF-b activity was added to 293T-
caga-Luc-CD32-CD86 cells. After 2, 5, 15, and 30 min, the cells were
lysed, and the lysates were run on SDS-PAGE. After transfer to a PVDF
membrane, the membrane was blotted with anti-phospho-Smad2 Ab,
and reblotted with anti-Smad2/3 Ab.
doi:10.1371/journal.pone.0018365.g006
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CD32-CD86 bioassay takes a molecular form that contains LAP as
a component. Since anti-LAP mAb TW7-20B9 does not cross-
react with human LAP (Figure S2), the new form of active TGF-b
is truly produced from murine CD4 T cells, but not from the
human 293T reporter cells.
T cell-produced TGF-b is not latent TGF-b
Since the T cell-produced TGF-b contains LAP, it may simply
represent the latent TGF-b complex and the 293T-caga-Luc-
CD32-CD86 reporter cells have a TGF-b activation machinery
which can initiate TGF-b signaling in response to latent TGF-b.T o
exclude this possibility, we added a commercially available
recombinant human latent TGF-b or a culture supernatant of
mouse TGF-b-transduced P3U1 cells to the 293T-caga-Luc-CD32-
CD86 reporter cells. We found that mouse TGF-b-transduced
P3U1 cells produced high amounts of latent TGF-b, as judged by a
TGF-b ELISA with or without acidification. However, both latent
TGF-b samples barely induced TGF-b signaling in the 293T-caga-
Luc-CD32-CD86 cells (Figure 9). Even at 4,000 pg/ml, recombi-
nant human latent TGF-b and mouse latent TGF-b-containing
supernatants induced only faint luciferase signals (equivalent to less
than 10 pg/ml recombinant TGF-b), which is likely explained by
the presence of contaminating active TGF-b which was detected by
ELISA without acidification (data not shown).
Cell type-specific responses to T cell-produced TGF-b
Since T cell-produced TGF-b activity takes an unconventional
TGF-b form, it is possible that it requires specific sensing
machineries and that only certain cell types respond to T cell-
produced TGF-b. To test this, we assayed T cell culture
supernatants on other TGF-b reporter cell lines. The Mv1Lu-
(caga)12-Luc cell line has the same the (caga)12-Luc reporter as the
293T-caga-Luc-CD32-CD86 cell line, and responds to recombi-
nant TGF-b in a dose-dependent manner. However, we found
that Mv1Lu-(caga)12-Luc cells did not respond to T cell culture
supernatants (Figure 10, middle). Another well-known TGF-b
bioassay reporter line is the mink lung epithelial cell (MLEC)-PAI-
1-Luc cell line which has a PAI-1 promoter-driven luciferase
reporter [21]; we found that MLEC-PAI-1-Luc cells also did not
respond to T cell-produced TGF-b (Figure 10, bottom). These
results indicate that T cell-produced TGF-b does not initiate TGF-
b signaling in all cell types, but it requires cell type-specific
molecular machineries to initiate TGF-b signaling.
Discussion
We have previously reported [22] a TGF-b bioassay for T cells
using the MLEC-PAI-1-Luc cell line, in which T cells were
coculturedwithreportercellsandstimulatedwithanti-CD3/CD28-
coated beads attached to the reporter cell surface. This bioassay
Figure 7. Immunologic depletion of ‘‘total’’ TGF-b from culture supernatants. (A) A T cell culture supernatant from plate-bound anti-CD3/
CD28 re-stimulated CD4
+CD25
2 T cells cultured in 10% TGF-b-depleted FBS IMDM was treated with control IgG1 mAb-coated magnetic beads or anti-
mouse LAP TW7-16B4 mAb-coated magnetic beads. The remaining ‘‘total’’ TGF-b in the culture supernatant was measured by TGF-b ELISA after
acidification. Error bars represent mean 6 S.D. of duplicates. (B) TGF-b activity in the same control IgG1-treated or anti-LAP TW7-16B4-treated T cell
culture supernatant was measured by the 293T-caga-Luc-CD32-CD86 bioassay after 630, 660 and 6120 dilutions.
doi:10.1371/journal.pone.0018365.g007
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+CD25
+ Tregs produced active TGF-b
which was neutralized with anti-TGF-b mAb 1D11. In order to
improve on this bioassay, we first modified the bioassay so that the
reporter cells behaved as artificial antigen presenting cells by
transducing MLEC-PAI-1-Luc cells with mouse CD32 (Fcreceptor)
for anti-CD3 capture and with mouse CD86 for costimulation.
Preliminary experiments showed that these CD32/CD86-trans-
duced MLEC-PAI-1-Luc cells were killed by murine pre-activated
CD4 T cells when T cells were co-cultured with the reporter cells in
the presence of anti-CD3. Thus, we chose 293T cell line as TGF-b
reportercellsasthiscell lineisresistanttoCD4-mediated killing.We
made a lentivirus based TGF-b reporter vector which contains
repeated CAGA Smad binding elements in the promoter region
linked luciferase (pSMPUW-(caga)12-Luc). 293T cells were trans-
duced with (caga)12-Luc, mouse CD32 and mouse CD86. Serpinb9
and Serpinb9b were also transduced as we found in preliminary
experiments that these granzyme inhibitor genes acted to lessen
CD4-mediated killing in MLEC-PAI-1-Luc cells.
Figure 8. Effects of anti-LAP or anti-latent TGF-b/pro-TGF-b mAbs on TGF-b activity in T cell culture supernatants. (A) Recombinant
human TGF-b was pre-mixed with anti-active TGF-b Abs (1D11 or chicken anti-TGF-b), an anti-LAP mAb (TW7-20B9), an anti-latent TGF-b/pro-TGF-b
mAb (TW7-28G11) (final 50 mg/ml), or ALK5 inhibitor II (final 1 mM), and then added to 293T-caga-Luc-CD32-CD86 reporter cells. (B) A T cell culture
supernatant containing an equivalent amount of TGF-b was pre-mixed with the indicated Abs or the ALK5 inhibitor, and added to 293T-caga-Luc-
CD32-CD86 cells. The luciferase activity was measured after 16 hr culture. Error bars represent mean 6 S.D. of duplicates.
doi:10.1371/journal.pone.0018365.g008
Figure 9. Response of 293T-caga-Luc-CD32-CD86 cells to latent TGF-b. Recombinant TGF-b, commercially available recombinant human
latent TGF-b or a diluted culture supernatant of mouse Tgfb1-transduced P3U1 cells was added to 293T-caga-Luc-CD32-CD86 cells and the resultant
luciferase activity was measured after 11 hrs. Error bars represent mean 6 S.D. of duplicates.
doi:10.1371/journal.pone.0018365.g009
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PLoS ONE | www.plosone.org 8 April 2011 | Volume 6 | Issue 4 | e18365When we used this new 293T-caga-Luc-CD32-CD86 reporter
cell to assay activated T cells, we found that activated T cells
produced high TGF-b activity in the 293T-caga-Luc-CD32-CD86
reporter cell assay even though we could not detect active TGF-b
production by ELISA. Furthermore, we found that activated
Foxp3
+ CD4 T cells that express surface LAP/TGF-b [14] had
lower TGF-b activity in the 293T-caga-Luc-CD32-CD86 reporter
cell assay than activated CD25
2 T cells. This TGF-b activity was
detected in T cell culture supernatants indicating that the T cell-
produced TGF-b was in the soluble form and was not membrane-
bound. These findings are in contrast to our previous observations
using MLEC-PAI-1-Luc cells [22] that when compared to
CD4
+CD25
2 T cells, activated CD4
+CD25
+ T cells had higher
TGF-b activity and this activity was linked to membrane bound
TGF-b. We believe that this difference is because the T cell-
produced TGF-b activity we observed using the 293T-caga-Luc-
CD32-CD86 reporter cell assay consists of an unconventional
form of TGF-b which can be measured by the 293T-caga reporter
cells but not by MLEC-PAI-1-Luc cells. Thus it appears that
Foxp3
+ Tregs produce the canonical form of mature TGF-b which
can be neutralized with anti-TGF-b mAb 1D11, whereas Foxp3
2
non-Tregs produce a new form of TGF-b which we have
identified with our new reporter assay and which can induce
TGF-b signaling in a cell type-specific manner.
Whether all activated CD4
+CD25
2 T cells produce this newly
described form of TGF-b or it is produced by a subset of
CD4
+CD25
2 cells is an important question. In addressing this
question, we found that CD4 T cells that produce this new form of
TGF-b reside primarily in the CD62L
2CD44
hi memory fraction
as opposed to the CD62L
+CD44
lo naive fraction (Figure S3).
Whether differentiated Th cell subsets such as Th1, Th2, Th17, or
Tr1 cells preferentially produce this form of TGF-b is an
interesting future question.
The molecular structure and/or composition of this new form of
TGF-b are unknown. It contains LAP as a component since the
TGF-b activity measured by the 293T-caga-Luc-CD32-CD86
reporter cell is neutralized by an anti-LAP mAb and by an anti-
latent TGF-b/pro-TGF-b mAb. Since mature TGF-b is not
released from the new form of TGF-b by acidification, this
suggests strong binding of the LAP segment to the TGF-b
segment. This may be because LAP is linked to TGF-b by covalent
bonding. Alternatively, disulfide bonding inside mature TGF-b
may take irregular forms that make the TGF-b segment
undetectable by ELISA even if the TGF-b segment is released
by acidification. Whatever the case, it should be noted that one
cannot detect the new form of TGF-b by ELISA even after
acidification. Thus, this new form of TGF-b does not appear to be
part of the ‘‘total’’ TGF-b detected by ELISA after acidification.
Figure 10. Cell type-specific responses to T cell-produced TGF-b. 293T-caga-Luc-CD32-CD86 cells (top), Mv1Lu-(caga)12-Luc cells (middle), or
MLEC-PAI-1-Luc cells (bottom) were exposed to recombinant TGF-b or diluted T cell culture supernatants. The luciferase activity was measured after
11 hr culture. Error bars represent mean 6 S.D. of duplicates.
doi:10.1371/journal.pone.0018365.g010
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PLoS ONE | www.plosone.org 9 April 2011 | Volume 6 | Issue 4 | e18365At this time we do not know what cell properties and/or
molecules are required to initiate TGF-b signaling by the new
form of TGF-b we have identified. In preliminary experiments, we
did not find that T cell-produced TGF-b induced Smad2
phosphorylation in CD4 T cells or in bone marrow-derived
DCs. However, it is possible that sub-populations of T cells or DCs
would respond T cell-produced TGF-b under special conditions.
In conclusion, our work demonstrates that murine CD4 T cells
produce an unconventional form of TGF-b which has biological
activity as measured by 293T-caga-Luc-CD32-CD86 reporter
cells but not by other assay systems and is not produced in
significant amounts by conventional Treg cells. Our finding of a
new form of T cell-produced TGF-b and the newly developed
TGF-b bioassay system will provide a new avenue to investigate T
cell function of the immune system.
Materials and Methods
Cell lines, Plasmids, and antibodies
The (caga)12-MLP-Luc vector was kindly provided from Dr. D.
Vivien (the Universite’ de Caen, Daix, France). Mv1Lu cells
(ATCC) were stably transfected with the (caga)12-MLP-Luc
plasmid (Mv1Lu-(caga)12-Luc cells). The mink lung epithelial cell
line transfected with the Smad-responsive plasminogen activator
inhibitor-1 promoter driving a luciferase reporter gene (MLEC-
PAI-1-Luc) (originally developed by Abe et al. [21]) was obtained
from Dr. L. van de Water (Massachusetts General Hospital,
Boston, MA, USA). A lentivirus based TGF-b reporter vector was
constructed by inserting the (caga)12-MLP-Luc segment into a
promoterless lentiviral vector pSMPUW (Cell Biolabs) along with
ubiquitin C promoter-driven a GFP-puro fusion gene as a
selection marker (pSMPUW-(caga)12-Luc). pMCs retroviral vector
was kindly provided Dr. T. Kitamura (Tokyo Univ., Tokyo,
Japan) and pBMN retroviral vector was from Addgene under a
MTA with Stanford University (Stanford, CA). A lentivirus
supernatant and retrovirus supernatants were produced as
described previously [23]. Human embryonic kidney 293T cells
(Clontech) were sequentially transduced with pSMPUW-(caga)12-
Luc, pBMN-mouse CD32 (without IRES), pBMN-mouse CD86
(without IRES), pMCs-Serpinb9-IRES-Thy1.1, and pMCs-Ser-
pinb9b-IRES-Thy1.2 vectors with cloning in each step. The
resultant cells were termed 293T-caga-Luc-CD32-CD86 cells.
Anti-TGF-b hybridoma 1D11 was from ATCC, and chicken anti-
TGF-b (AF-101-NA) was from R&D Systems. Anti-mouse LAP
mAbs TW7-16B4 and TW7-20B9, and anti-latent TGF-b/pro-
TGF-b mAb TW7-28G11 were described previously [14]. Anti-
FasL (clone MFL3) was from BioLegend. ALK5 inhibitor II was
from EMD/Calbiochem.
CD4 T cell preparation and stimulation
Mice were housed in a pathogen-free environment and the
animal protocols were approved by the Committee on Animals of
Harvard Medical School (Harvard Medical Area Standing
Committee on Animals, Protocol No. 02683). CD4 T cells were
separated from BALB/c mice (The Jackson Laboratories) using a
MACS CD4 purification kit (Miltenyi Biotec). When
CD4
+CD25
2 T cells were prepared, biotinylated anti-CD25
antibody (7D4, BD Biosciences) was additionally mixed to the
MCAS antibody cocktail. CD4
+CD25
+ T cells were prepared
from the CD4 fraction by staining CD25-FITC (7D4, BD
Biosciences) followed by anti-FITC MACS beads (Miltenyi
Biotec), and by MS column separation. T cells were stimulated
with plate-bound anti-CD3 and anti-CD28 (5 mg/ul each) for 2
days in 10% FBS-supplemented IMDM. In case of CD4
+CD25
+
T cell stimulation, 100 U/ml recombinant IL-2 was added both in
CD4
+CD25
+ T cell cultures and in CD4
+CD25
2 T cell cultures.
The cells were split into non-coated wells and rested for 1 day. The
cells were recovered, washed with the culture medium, counted,
and used for the TGF-b bioassay, or re-stimulated with plate-
bound anti-CD3/CD28 for 24 h hrs for culture supernatants.
When indicated, TGF-b-depleted FBS [20] was used for the
culture medium.
TGF-b ELISA
TGF-b ELISA was performed using anti-TGF-b mAb 1D11 as
a coating antibody and biotinylated chicken anti-TGF-b IgY
(BAF240, R&D Systems) as a detection antibody. Recombinant
human TGF-b (R&D Systems) was used as a standard (0–
2,000 pg/ml). Sample acidification was done by adding 1/10
volume of 1 N HCl, incubating at room temperature for 10 min,
and neutralizing with 1/10 volume of 1 N NaOH/0.1 M Tris.
The samples were then diluted twofold by adding 25 mM Tris
buffered saline.
TGF-b bioassay
293T-caga-Luc-CD32-CD86 TGF-b reporter cells were seeded
at 2610
4 cells/100 ml/well on collagen-coated 96-well plates 1 day
before addition of T cells. On the day of assay, 10 ml of 1 mg/ml
anti-CD3 (145-2C11) (BD Biosciences) was added to each well
(final 0.5 mg/ml). When CD4
+CD25
+ T cells were tested, IL-2 was
also added to final 100 U/ml. Pre-activated CD4 T cells or
recombinant human TGF-b (R&D Systems) were added at
100 ml/well (final total volume 210 ml/well) and cultured for
16 hrs. Similarly, the TGF-b bioassay from culture supernatants
was conducted by adding 100 ml of diluted T cell culture
supernatants to 293T-caga-Luc-CD32-CD86 cell culture wells
and the reporter cells were cultured for the indicated time. When
neutralizing antibodies were tested, T cell culture supernatants
were diluted to be equivalent to 200 pg/ml recombinant TGF-b
activity and were then premixed with the antibodies at 100 mg/ml
for 30 min at room temperature. 100 ml of the mixture was added
to 100 ml of 293T-caga-Luc-CD32-CD86 reporter wells. 293T-
caga-Luc-CD32-CD86 cells were lysed with Glo-Lysis buffer
(Promega), and luciferase activity was measured by ONE-Glo
luciferease assay reagent (Promega).
Detection of Smad2 phosphorylation
293T-caga-Luc-CD32-CD86 cells were exposed to recombi-
nant human TGF-b (1 ng/ml) or a T cell culture supernatant
diluted by TGF-b activity determined by the 293T-caga-Luc-
CD32-CD86 bioassay equivalent to 1 ng/ml TGF-b. After 2, 5,
15, and 30 min, the cells were lysed with 1% Triton X-100, 0.25%
deoxycholate, 0.1% SDS, 1 mM NaVO4, protease inhibitor
cocktail (Pierce/Thermo), 25 mM Tris buffered saline. The lysates
were clarified by centrifugation at 13,000 rpm for 15 min, and run
on SDS-PAGE under reducing conditions. Western blot was
conducted with rabbit anti-phospho-Smad2(Ser465/467) antibody
(Cell Signaling) and with rabbit anti-Smad2/3 antibody (Cell
Signaling).
Depletion of ‘‘total’’ TGF-b from culture supernatants
with an anti-LAP Ab
400 ml of 1 mg/ml of anti-mouse IgG magnetic beads (BioMag
Plus, Polysciences) was placed in a 1.5 ml microcentrifuge tube
and the beads were washed with PBS three times. 400 ml PBS
containing 20 mg of anti-mouse LAP mAb TW7-16B4 or isotype
control MOPC21 was added to the beads and incubated with
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PLoS ONE | www.plosone.org 10 April 2011 | Volume 6 | Issue 4 | e18365rotation for 4 hrs. After washing with PBS three times, 0.6 ml of
the T cell culture supernatant from plate-bound anti-CD3/CD28
re-stimulated CD4
+CD25
2 T cells in 10% TGF-b-depleted FBS
IMDM was added to the bead pellets, and incubated at 4uC for
overnight. The unbound supernatant was recovered by magnetic
separation. The amount of TGF-b before and after separation was
measured by TGF-b ELISA after acidification.
Latent TGF-b
Recombinant human latent TGF-b was purchased from R&D
Systems. Recombinant mouse latent TGF-b was made as a culture
supernatant of mouse Tgfb1-transduced P3U1 cells. The 16
culture supernatant contained 84 ng/ml total TGF-b (mostly
latent TGF-b) and 142 pg/ml active TGF-b determined by TGF-
b ELISA with, and without acidification, respectively.
Supporting Information
Figure S1 Effect of blocking anti-Fas Ligand antibody to
T cell-produced TGF- b. Pre-activated CD4 T cells were
harvested on day 4, which is one day delayed compared with the
regular stimulation (day 3 recovery), and the CD4 T cells were co-
cultured with 293T-caga-Luc-CD32-CD86 reporter cells in
presence of blocking anti-FasL mAb.
(TIF)
Figure S2 Species specificity of TW7 antibodies. human
TGFB1-transduced P3U1 cells (clone 32, without IRES-GFP)
(GFP
2 population) and mouse Tgfb1-transduced P3U1 cells (clone
11, containing IRES-GFP) (GFP
+ population) were mixed and
surface stained with TW7-16B4, TW7-20B9, or TW7-28G11
mAb. TW7-16B4 and TW7-20B9 stained only mouse Tgfb1-
transduced cells while TW7-28G11 stained both human TGFB1-
transduced cells and mouse Tgfb1-transduced cells.
(TIF)
Figure S3 Production of TGF-b activity from naı ¨ve CD4
T cells and memory CD4 T cells. CD62L
+CD44
lo naı ¨ve CD4
T cells or CD62L
loCD44
hi memory CD4 T cells were stimulated
with plate-bound anti-CD3/CD28 for 2 days, and rested for 1
day. The pre-activated CD4 T cells were recovered, and the
indicated numbers of T cells were added to 293T-caga-Luc-
CD32-CD86 cells with 0.5 mg/ml of anti-CD3 antibody. Recom-
binant human TGF-b was also added as a standard. After 16 hr
culture, the reporter cells were lysed and the luciferase activity was
measured. Error bars represent mean 6 S.D. of duplicates.
(TIF)
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